<p>We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.</p>

We discuss the baseline characteristics of eyes in the HD Aflibercept Phase III clinical trial and examine their ability for extended dosing with Dr. Eric Schneider of Tennessee Retina, Nashville, TN.

The High Dose Aflibercept DME Trial

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Share The High Dose Aflibercept DME Trial

Sign up to save your podcasts

The High Dose Aflibercept DME Trial

The High Dose Aflibercept DME Trial

More shows like Retina Synthesis

Straight From The Cutter's Mouth: A Retina Podcast